A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data

Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden

(2021) Jonas F Ludvigsson et al.   Clinical Epidemiology

Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide

(2021) Fei Li et al.   Nature Communications

5α-Reductase Inhibitors are Associated with Reduced Risk of SARS-COV-2 Infection: A Matched-Pair, Registry-Based Analysis.

(2021) Madison Lyon et al.   JOURNAL OF UROLOGY

The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells

(2021) D. A. Leach et al.   Nature Communications

Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial

(2021) John McCoy et al.   Frontiers in Medicine

Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)

(2020) M. Montopoli et al.   ANNALS OF ONCOLOGY

Surgical mask partition reduces the risk of non-contact transmission in a golden Syrian hamster model for Coronavirus Disease 2019 (COVID-19)

(2020) Jasper Fuk-Woo Chan et al.   CLINICAL INFECTIOUS DISEASES

Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients – the “Gabrin sign”

(2020) Carlos Gustavo Wambier et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Viral and host factors related to the clinical outcome of COVID-19

(2020) Xiaonan Zhang et al.   NATURE

Does androgen deprivation therapy protect against severe complications from COVID-19?

(2020) V.G. Patel et al.   ANNALS OF ONCOLOGY

Androgen deprivation and SARS-CoV-2 in men with prostate cancer

(2020) M. Koskinen et al.   ANNALS OF ONCOLOGY

Factors associated with COVID-19-related death using OpenSAFELY

(2020) Elizabeth J. Williamson et al.   NATURE

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

(2020)   NEW ENGLAND JOURNAL OF MEDICINE

Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission

(2020) Hannah Peckham et al.   Nature Communications

Pharmacokinetic Drug Interaction Studies with Enzalutamide

(2015) Jacqueline A. Gibbons et al.   CLINICAL PHARMACOKINETICS

Androgen receptor and androgen-dependent gene expression in lung

(2009) Laura Mikkonen et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY